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A commentary on
Heart Fat Infiltration In Subjects With and Without Coronary Artery Disease
by Mazzali G, Fantin F, Zoico E, Sepe A, Bambace C, Faccioli S, et al. J Clin Endocrinol Metab (2015) 
100(9):3364–71. doi:10.1210/jc.2015-1787
Mazzali et al. showed myocardial steatosis in subjects with coronary artery disease (CAD), describ-
ing a significant increase in lipid droplets (LDs) and metabolically active adipocytes interspersed 
among cardiomyocytes, which were positively associated with changes in BMI and circulating leptin 
and negatively with adiponectin (1).
The authors used perilipin (PLIN-1) and adipophilin (PLIN-2) markers to detect, respectively, 
adipocyte or cardiomyocytes LDs and reported that while PLIN-2 was detected in all subjects, about 
39% of both CAD and non-CAD patients expressed PLIN-1, showing apparently no relationship 
in tissue fat distribution between patients and controls. Yet, when intra-cardiomyocyte fat deposits 
were evaluated, subjects with CAD expressed higher levels of both PLIN-1 and PLIN-2 and higher 
LD diameter than controls, besides apoptosis and hypoxia markers (1). The observed higher 
amount of PLIN-1 and PLIN-2, evaluated by immunohistochemistry rather than gene expression, 
correlated with some metabolic serum markers. While PLIN-1 seems to be associated with larger 
triacylglycerol LDs in mature adipocytes, PLIN-2 is mainly associated with LDs in non-steroidal 
adipose tissues (2). LDs are usually collectively grouped in the PAT family, which includes perilipins 
(P), ADRP (also called adipophilin) (A), Tip-47 (tail-interacting protein of 47 kDa) (T), hence the 
acronym PAT. They also include S3–12 and OXPAT (also termed MLDP or LSDP5) and recently, 
respectively, named PLIN1, PLIN2, PLIN3, PLIN4, and PLIN5 (3). The use of PLIN-1 and PLIN-2 
is particularly useful in evaluating fat deposits in tissues, although some question still remains, as 
LD proteins are expressed in a highly complex way during lipidogenesis in the adipose cell (4). In 
this perspective, some further markers to improve adipocyte detection, such as CIDEC, might be 
suggested (5–7), in order to better differentiate adipocytes from LDs and also to reduce bias during 
the immunological detection of perilipin isoforms, as they share a high sequence homology and 
modification in their N- or C-terminus, depending on their function (4). Unlike other perilipins, 
PLIN-1 is widely associated with any LD moving from membranes and endoplasmic reticulum to 
fat droplets during lipid synthesis in any steroidogenic cells and probably may not be a specific 
marker of isolated white adipocytes (8). Furthermore, the expression of PLIN-2, which the authors 
associated with LDs in cells different from adipocytes, has also been reported in brown adipocytes (9) 
and adipocytes from white adipose tissue may express adipophilin (PLIN-2), in particular metabolic 
conditions (4). Expanding this investigation with further insights may improve the meaning of the 
reported evidence. For example, perilipin-5 (PLIN-5), which is an important marker in cardiac con-
trol of lipolysis (10), is particularly abundant in the heart (11), and as its overexpression could lead 
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to myocardial steatosis, including this marker in future research 
on myocardial lipidology, particularly in CAD, may improve our 
knowledge and ability to address this issue (12, 13).
Isolated adipocytes within the myocardium are not a true nov-
elty (14), as adipose tissue was described also within myocardial 
ventricular walls (15) and recently confirmed in atrial dysfunc-
tion (16). Further research in this field should address the origin 
of these adipocytes, e.g., one could investigate the presence of 
fibroblast-like preadipocytes in the atrium, which may add fur-
ther insights on the issue (17). The origin of these adipocytes is 
fundamental to comprehend their role in CAD. Epicardial adipose 
tissue (EAT) in specimens may cause possible bias, as adipocytes 
observed within the atrium may derive from epicardium or even a 
tissue-related mesenchymal transdifferentiation mechanism (1). 
Interestingly, pericytes may be sources of preadipocytes, likewise 
endothelial cells in the adipose tissue, and represent a possible 
source of the observed adipocytes (18, 19). Once highlighted the 
origin of interspersed adipocytes, one could question, which is the 
possible role of these cells, namely if they even play a major role 
in some compensatory mechanism triggered by myocardial tissue 
to prevent serious damage due to CAD. The recently reported 
evidence that at least in skeletal muscle, the increase in PLIN-2 
correlated with an improvement in insulin sensitivity in diabetic 
subjects is intriguing (20). Despite the observation of apoptotic 
and stress response, signals associated with hypoxia and mito-
chondrial impairment and dysfunction lead to LDs formation as 
a positive response to cellular stress (21). In this context, observed 
adipocytes, which would deserve further clarification about their 
nature, may shed a light on a possible role in the heart reaction to 
cardiovascular damage.
PLIN-1 is expressed also by brown adipocytes (8, 22). 
Further investigation on the main brown adipocyte marker, the 
uncoupling protein-1 (UCP-1), should differentiate the nature 
of the observed adipocytes (23, 24). This fact may be important 
to clarify the role of these cells in the myocardial tissue of CAD 
patients. Following a suggestion about the possible existence 
of adipocytes from adult stem cells (ASCs), brown adipose 
tissue (BAT) is an interesting precursor of cardiomyocytes, 
as subepicardial fat embryologically derives from BAT and 
because in aged hearts, a protective mechanism of differentia-
tion of subepicardial stem cells into BAT was recently described 
(23). The use of UCP-1, to elucidate the nature of interspersed 
adipocytes, may support the hypothesis that adipocytes serve as 
an important source to compensate myocardial damage in CAD 
patients. Adipocytes within myocardial tissue may even have a 
protective, damage-repairing role, a suggestion supported by 
the recent evidence that adipose tissue-derived stem cells exert 
paracrine actions that may have therapeutic effect on myocardial 
dysfunction (25).
While the authors showed a greater myocardial steatosis in 
subjects with CAD compared with controls, further research 
should deepen the role of interspersed adipocytes, their origin, 
and cytological nature. Suggestions coming from animal models 
and further experimental research will add insights to the nature 
of this study, highlighting the mechanism of the mesenchymal 
source and the role of these cells in the atrium.
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